These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21384276)

  • 1. Association study between four polymorphisms in the HFE, TF and TFR genes and Parkinson's disease in southern Italy.
    Greco V; De Marco EV; Rocca FE; Annesi F; Civitelli D; Provenzano G; Tarantino P; Scornaienchi V; Pucci F; Salsone M; Novellino F; Morelli M; Paglionico S; Gambardella A; Quattrone A; Annesi G
    Neurol Sci; 2011 Jun; 32(3):525-7. PubMed ID: 21384276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
    Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
    Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
    Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
    Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between the C282Y and H63D polymorphisms of HFE gene and the risk of Parkinson's disease: A meta-analysis.
    Xia J; Xu H; Jiang H; Xie J
    Neurosci Lett; 2015 May; 595():99-103. PubMed ID: 25863172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor.
    Lebrón JA; West AP; Bjorkman PJ
    J Mol Biol; 1999 Nov; 294(1):239-45. PubMed ID: 10556042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants in iron metabolism genes predict higher blood lead levels in young children.
    Hopkins MR; Ettinger AS; Hernández-Avila M; Schwartz J; Téllez-Rojo MM; Lamadrid-Figueroa H; Bellinger D; Hu H; Wright RO
    Environ Health Perspect; 2008 Sep; 116(9):1261-6. PubMed ID: 18795173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.
    de Tayrac M; Roth MP; Jouanolle AM; Coppin H; le Gac G; Piperno A; Férec C; Pelucchi S; Scotet V; Bardou-Jacquet E; Ropert M; Bouvet R; Génin E; Mosser J; Deugnier Y
    J Hepatol; 2015 Mar; 62(3):664-72. PubMed ID: 25457201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders.
    Beckman LE; Van Landeghem GF; Sikström C; Wahlin A; Markevärn B; Hallmans G; Lenner P; Athlin L; Stenling R; Beckman L
    Carcinogenesis; 1999 Jul; 20(7):1231-3. PubMed ID: 10383894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of haemochromatosis gene mutations in Parkinson's disease.
    Aamodt AH; Stovner LJ; Thorstensen K; Lydersen S; White LR; Aasly JO
    J Neurol Neurosurg Psychiatry; 2007 Mar; 78(3):315-7. PubMed ID: 17056630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload.
    De Gobbi M; Daraio F; Oberkanins C; Moritz A; Kury F; Fiorelli G; Camaschella C
    Haematologica; 2003 Apr; 88(4):396-401. PubMed ID: 12681966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HFE gene mutations in a population of Italian Parkinson's disease patients.
    Biasiotto G; Goldwurm S; Finazzi D; Tunesi S; Zecchinelli A; Sironi F; Pezzoli G; Arosio P
    Parkinsonism Relat Disord; 2008; 14(5):426-30. PubMed ID: 18325820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.
    Robson KJ; Lehmann DJ; Wimhurst VL; Livesey KJ; Combrinck M; Merryweather-Clarke AT; Warden DR; Smith AD
    J Med Genet; 2004 Apr; 41(4):261-5. PubMed ID: 15060098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease.
    Giambattistelli F; Bucossi S; Salustri C; Panetta V; Mariani S; Siotto M; Ventriglia M; Vernieri F; Dell'acqua ML; Cassetta E; Rossini PM; Squitti R
    Neurobiol Aging; 2012 Aug; 33(8):1633-41. PubMed ID: 21514009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
    Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
    J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HFE gene variants modify the association between maternal lead burden and infant birthweight: a prospective birth cohort study in Mexico City, Mexico.
    Cantonwine D; Hu H; Téllez-Rojo MM; Sánchez BN; Lamadrid-Figueroa H; Ettinger AS; Mercado-García A; Hernández-Avila M; Wright RO
    Environ Health; 2010 Jul; 9():43. PubMed ID: 20659343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of HFE-induced regulation of iron homeostasis: Insights from the W81A HFE mutation.
    Zhang AS; Davies PS; Carlson HL; Enns CA
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9500-5. PubMed ID: 12874382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy.
    De Marco F; Liguori R; Giardina MG; D'Armiento M; Angelucci E; Lucariello A; Morante R; Cimino L; Galeota-Lanza A; Tarantino G; Ascione A; Budillon G; Vecchione R; Martinelli R; Matarazzo M; De Simone V
    Clin Chem Lab Med; 2004 Jan; 42(1):17-24. PubMed ID: 15061375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of HFE variants in Spanish patients: association with HLA alleles and role in susceptibility to acute lymphoblastic leukemia.
    Rodríguez-López R; Donoso M; Fernández-Cavada M; González LM; Margallo A; Corral C; Gallego M; García de Cáceres MT; Herrera T; González C; Vagace JM; Gervasini G
    Gene; 2013 Feb; 514(1):31-5. PubMed ID: 23178241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface.
    Giannetti AM; Björkman PJ
    J Biol Chem; 2004 Jun; 279(24):25866-75. PubMed ID: 15056661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron genes, iron load and risk of Alzheimer's disease.
    Lehmann DJ; Worwood M; Ellis R; Wimhurst VL; Merryweather-Clarke AT; Warden DR; Smith AD; Robson KJ
    J Med Genet; 2006 Oct; 43(10):e52. PubMed ID: 17047092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.